Advocacy groups leaders and cancer experts express hope for increased funding and attention to cancer research during President Biden administration. more→
Changing the landscape of pediatric research
Requires companies developing molecularly targeted cancer drugs to undertake pediatric studies.
MORE »
Has created over $1.5 billion of voucher incentives for rare pediatric drug development.
MORE »
We support physicians’ efforts to save children by helping to obtain investigational drugs.
MORE »
We help families of children with terminal brain cancer donate their child’s post mortem tumor tissue to research.
MORE »
We applaud the FDA’s new guidance urging companies to include teens on adult cancer trials when appropriate.
MORE »
Leave your parents and teachers behind. A day on Capitol Hill for kids to be the voice of children with cancer. Next up: TBA.
Register here »
Join us for Climb the Hill Advocacy Days on Capitol Hill. Sign-up here! See photos and watch the video of our young advocates.
Please donate online. Checks can be sent to: Kids v Cancer, 3500 Macomb St. NW, Washington D.C. 20016.
Spread the word to help families seek compassionate use drugs or donate autopsy tissue for research.
Have you, or your sibling, or your child had cancer? We’d love to include your story in a book for Congress.
Advocacy groups leaders and cancer experts express hope for increased funding and attention to cancer research during President Biden administration. more→
Kids v Cancer is proud to announce that Congress passed the Creating Hope Reauthorization Act as part of the Stimulus Package. This win will create a four year extension to the pediatric voucher program, incentivizing drug development for kids with life threatening illnesses. more→
A new drug for neuroblastoma and three more drugs for rare pediatric diseases approved during Thanksgiving week, earning the vouchers under the Creating Hope Act. more→
The House of Representatives passed the Creating Hope Reauthorization Act to extend the rare pediatric disease voucher program for four years. more→
Testimony before the Health Subcommittee of the U.S. House of Representatives Energy and
Commerce Committee, July 29, 2020. Nancy Goodman, Founder of Kids v Cancer more→
The Research to Accelerate Cures and Equity (RACE) for Children Act has the potential to substantially increase the number of required pediatric studies for novel anticancer drugs, according to an analysis of previously approved agents and RACE criteria. more→